Document registry — page 14

• Register entry: Dr Kamila Glendinning-Uche

  CEI-RG-184Register entry2026-q3

  Comment-period correspondent, peptide chemistry. University department of medicinal chemistry

  30 Jul 2026
• Register entry: Dr Benedikt Quenneville

  CEI-RG-185Register entry2026-q3

  Submitted-evidence contributor, clinical pharmacology. Academic clinical pharmacology unit

  30 Jul 2026
• Register entry: Anselm Mountstephen

  CEI-RG-186Register entry2026-q3

  Comment-period correspondent, medicines information. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Fenella Lavrentiev

  CEI-RG-187Register entry2026-q3

  Comment-period correspondent, endocrinology. Endocrine surgery service

  30 Jul 2026
• Register entry: Dr Ulysses Ubertini

  CEI-RG-188Register entry2026-q3

  Submitted-evidence contributor, toxicology. University department of medicinal chemistry

  30 Jul 2026
• Register entry: Dr Ursina Ellsworth-Vance

  CEI-RG-189Register entry2026-q3

  External reviewer, hepatology. University department of hepatology

  30 Jul 2026
• Register entry: Dr Frideswide Nordhagen

  CEI-RG-190Register entry2026-q3

  Comment-period correspondent, pharmacy practice. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Odalys Quintanilha

  CEI-RG-191Register entry2026-q3

  Submitted-evidence contributor, regulatory science. Health-technology assessment agency

  30 Jul 2026
• Register entry: Dr Lorcan Uttridge

  CEI-RG-192Register entry2026-q3

  Specialist adviser, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Quintus Kettlewell

  CEI-RG-193Register entry2026-q3

  Comment-period correspondent, toxicology. National pharmacovigilance centre

  30 Jul 2026
• Register entry: Dr Wojciech Oyelaran-Steen

  CEI-RG-194Register entry2026-q3

  Submitted-evidence contributor, mass spectrometry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Dr Radoslava Palmgren-Kofi

  CEI-RG-195Register entry2026-q3

  External reviewer, nephrology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Delphine Trelawney

  CEI-RG-196Register entry2026-q3

  External reviewer, clinical pharmacology. Academic clinical pharmacology unit

  30 Jul 2026
• Register entry: Dr Katarzyna Yorkstone

  CEI-RG-197Register entry2026-q3

  External reviewer, cardiovascular outcomes. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ludmila Castellanos-Reid

  CEI-RG-198Register entry2026-q3

  External reviewer, paediatric endocrinology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Quentin Gwynne-Sarpong

  CEI-RG-199Register entry2026-q3

  Comment-period correspondent, public health. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ivo Quintanilha

  CEI-RG-200Register entry2026-q3

  Comment-period correspondent, evidence synthesis. University department of public health

  30 Jul 2026
• Register entry: Dr Dmitri Nordhagen

  CEI-RG-201Register entry2026-q3

  Specialist adviser, endocrinology. Metabolic medicine service, tertiary centre

  30 Jul 2026
• Register entry: Dr Torvald Kettlewell

  CEI-RG-202Register entry2026-q3

  External reviewer, cardiovascular outcomes. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Jolanta Uttridge

  CEI-RG-203Register entry2026-q3

  Comment-period correspondent, pharmaceutics. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Vasilisa Sandringham-Adu

  CEI-RG-204Register entry2026-q3

  External reviewer, public health. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ngozi Zetterlund

  CEI-RG-205Register entry2026-q3

  Comment-period correspondent, paediatric endocrinology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Ciarán Jankowiak-Osei

  CEI-RG-206Register entry2026-q3

  Submitted-evidence contributor, microbiological quality. Hospital microbiology and endotoxin testing service

  30 Jul 2026
• Register entry: Dr Theodora Trelawney

  CEI-RG-207Register entry2026-q3

  External reviewer, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Dr Perpetua Haverkamp-Diallo

  CEI-RG-208Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Bertrand Ollerenshaw

  CEI-RG-209Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Dr Liesbeth Nordhagen

  CEI-RG-210Register entry2026-q3

  Comment-period correspondent, regulatory science. Global regulatory policy, marketing-authorisation holder

  30 Jul 2026
• Register entry: Ngozi Brackenridge

  CEI-RG-211Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector

  30 Jul 2026
• Register entry: Dr Matthias Wintringham

  CEI-RG-212Register entry2026-q3

  Comment-period correspondent, regulatory science. Medical affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Saoirse Petrossian

  CEI-RG-213Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, contract development and manufacturing organisation

  30 Jul 2026
• Register entry: Dr Wolfram Quintanilha

  CEI-RG-214Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Jacinta Ravensworth

  CEI-RG-215Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector

  30 Jul 2026
• Register entry: Dr Constança Glendinning-Uche

  CEI-RG-216Register entry2026-q3

  Comment-period correspondent, health-technology assessment. Health-technology assessment agency

  30 Jul 2026
• Register entry: Dr Evander Ashworth-Danquah

  CEI-RG-217Register entry2026-q3

  Comment-period correspondent, health-technology assessment. Health-technology assessment agency

  30 Jul 2026
• Synthesis: Exenatide in type 2 diabetes mellitus: effect on the anchor outcome

  CEI-ES-042Evidence synthesis2026-q3

  In the population defined for type 2 diabetes mellitus, what is the effect of Exenatide compared with the comparator used in its contributing trials on the anchor…

  High28 Jul 2026
• Draft standard CEI-MS-20: Photostability assessment of light-sensitive peptides

  CEI-CP-097Public comment period2026-q2

  Consultation on the draft of CEI-MS-20, which specifies the performance a determination must achieve for stability and states what the resulting figure does not…

  26 Jul 2026
• Indication assessment: Biological ageing and healthspan endpoints

  CEI-IN-30Indication assessment2026-q3

  Interventions proposed to modify rate of biological ageing, assessed by composite biomarker clocks, functional measures, or mortality.

  25 Jul 2026
• Supplier dossier: Shanghai Wibson Biotechnology Co., Ltd.

  CEI-SD-13Supplier dossier2025-q4

  Peptides, SARMs, injectable oils and raw materials.

  23 Jul 2026
• Draft scoping review: change in lean mass during pharmacologically induced weight reduction

  CEI-CP-017Public comment period2026-q2

  Consultation on the draft scoping review of change in lean mass during pharmacologically induced weight reduction. The review is scoping rather than an intervention…

  21 Jul 2026
• Draft monograph: CJC-1295

  CEI-CP-044Public comment period2026-q3

  Consultation on the draft monograph for CJC-1295, which the assessment committee released for public comment before ratification. The draft grades the compound's…

  21 Jul 2026

page 14 of 41